  In August 2013, the French pharmacopoeia was enriched with 43 plants used in
French overseas territories, including 15 proposed by APLAMEDAROM association
of Guadeloupe. However, for most of them, no data on the chemical composition,
qualitatively and quantitatively is available in the literature for these
specimens; this is an issue to their commercialization in dispensary,
pharmacists wishing to know their composition in order to avoid the problems of
dosage and drug interactions. Among these plants, Phyllanthus amarus Schum. \&
Thonn. (1827), commonly called 'Grenn anba f{\`e}y' [1], is well known for its
potent medicinal properties especially hepatoprotective, antidiabetic,
antiviral (flu), anti-inflammatory, anti-cholesterol [2]. In Guadeloupe, this
plant is generally used freshly harvested in infusion but also in aqueous
decoction [3]. Besides, these studies are conducted in association with
APLAMEDAROM association in order to identify the polar constituents and then to
understand better the origin of the observed properties. Therefore, using
UHPLC-MS, we were able to identify the presence of bioactive polyphenolic
compounds, including phyllanthin, rutin and gallic acid. Phyllanthin,
characteristic of the specie, is a very active lignan with high antioxidant,
hepatoprotective and anticancer properties [2]. Rutin is known for its
antioxidant and anti-hypertensive properties [2]. Gallic acid is distinguished
by antioxidant, anti-inflammatory, antidiabetic, antiviral and anticancer
properties and has the advantage of being a bioavailable compound. Similarly,
many compounds never listed to date in this specie were also highlighted and
are currently purified.
